vs

Side-by-side financial comparison of Emerson Electric (EMR) and LPL Financial Holdings Inc. (LPLA). Click either name above to swap in a different company.

LPL Financial Holdings Inc. is the larger business by last-quarter revenue ($4.9B vs $4.6B, roughly 1.1× Emerson Electric). Emerson Electric runs the higher net margin — 13.5% vs 7.2%, a 6.3% gap on every dollar of revenue. On growth, LPL Financial Holdings Inc. posted the faster year-over-year revenue change (34.6% vs 3.0%). Over the past eight quarters, LPL Financial Holdings Inc.'s revenue compounded faster (29.8% CAGR vs -0.6%).

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

LPL Financial Holdings Inc. was founded in 1989 and is considered the largest independent broker-dealer in the United States. As of 2021 the company had more than 17,500 financial advisors, over US$1 trillion in advisory and brokerage assets, and generated approximately $10.3 billion in annual revenue for the 2023 fiscal year. LPL Financial has main offices in Boston, Fort Mill, Austin, and San Diego. The company is a member of FINRA and the SIPC.

EMR vs LPLA — Head-to-Head

Bigger by revenue
LPLA
LPLA
1.1× larger
LPLA
$4.9B
$4.6B
EMR
Growing faster (revenue YoY)
LPLA
LPLA
+31.6% gap
LPLA
34.6%
3.0%
EMR
Higher net margin
EMR
EMR
6.3% more per $
EMR
13.5%
7.2%
LPLA
Faster 2-yr revenue CAGR
LPLA
LPLA
Annualised
LPLA
29.8%
-0.6%
EMR

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
EMR
EMR
LPLA
LPLA
Revenue
$4.6B
$4.9B
Net Profit
$618.0M
$356.4M
Gross Margin
53.1%
32.3%
Operating Margin
Net Margin
13.5%
7.2%
Revenue YoY
3.0%
34.6%
Net Profit YoY
43.7%
EPS (diluted)
$1.10
$4.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EMR
EMR
LPLA
LPLA
Q2 26
$4.6B
Q1 26
$4.3B
$4.9B
Q4 25
$4.3B
$4.9B
Q3 25
$4.9B
$4.6B
Q2 25
$4.6B
$3.8B
Q1 25
$4.4B
$3.7B
Q4 24
$4.2B
$3.5B
Q3 24
$4.6B
$3.1B
Net Profit
EMR
EMR
LPLA
LPLA
Q2 26
$618.0M
Q1 26
$606.0M
$356.4M
Q4 25
$605.0M
$300.7M
Q3 25
$637.0M
$-29.5M
Q2 25
$586.0M
$273.2M
Q1 25
$485.0M
$318.6M
Q4 24
$585.0M
$270.7M
Q3 24
$996.0M
$255.3M
Gross Margin
EMR
EMR
LPLA
LPLA
Q2 26
53.1%
Q1 26
53.2%
32.3%
Q4 25
53.2%
Q3 25
51.9%
Q2 25
52.6%
Q1 25
53.5%
Q4 24
53.5%
Q3 24
51.3%
Operating Margin
EMR
EMR
LPLA
LPLA
Q2 26
Q1 26
Q4 25
17.8%
8.1%
Q3 25
16.4%
-0.7%
Q2 25
16.1%
9.6%
Q1 25
14.2%
11.4%
Q4 24
18.6%
9.7%
Q3 24
14.7%
11.2%
Net Margin
EMR
EMR
LPLA
LPLA
Q2 26
13.5%
Q1 26
13.9%
7.2%
Q4 25
13.9%
6.1%
Q3 25
13.1%
-0.6%
Q2 25
12.9%
7.1%
Q1 25
10.9%
8.7%
Q4 24
14.0%
7.7%
Q3 24
21.6%
8.2%
EPS (diluted)
EMR
EMR
LPLA
LPLA
Q2 26
$1.10
Q1 26
$1.07
$4.43
Q4 25
$1.07
$3.65
Q3 25
$1.12
$-0.37
Q2 25
$1.04
$3.40
Q1 25
$0.86
$4.24
Q4 24
$1.02
$3.58
Q3 24
$1.74
$3.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EMR
EMR
LPLA
LPLA
Cash + ST InvestmentsLiquidity on hand
$1.8B
$1.0B
Total DebtLower is stronger
$13.4B
Stockholders' EquityBook value
$20.3B
$5.7B
Total Assets
$42.1B
$18.8B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EMR
EMR
LPLA
LPLA
Q2 26
$1.8B
Q1 26
$1.7B
$1.0B
Q4 25
$1.1B
Q3 25
$1.6B
Q2 25
$4.3B
Q1 25
$1.4B
Q4 24
$1.0B
Q3 24
$1.6B
Total Debt
EMR
EMR
LPLA
LPLA
Q2 26
$13.4B
Q1 26
$13.4B
Q4 25
$7.6B
$7.3B
Q3 25
$8.9B
$7.5B
Q2 25
$8.3B
$7.2B
Q1 25
$8.2B
$5.7B
Q4 24
$6.6B
$5.5B
Q3 24
$7.7B
$4.4B
Stockholders' Equity
EMR
EMR
LPLA
LPLA
Q2 26
$20.3B
Q1 26
$20.3B
$5.7B
Q4 25
$20.3B
$5.3B
Q3 25
$20.3B
$5.0B
Q2 25
$19.9B
$5.1B
Q1 25
$19.2B
$3.1B
Q4 24
$20.5B
$2.9B
Q3 24
$21.6B
$2.8B
Total Assets
EMR
EMR
LPLA
LPLA
Q2 26
$42.1B
Q1 26
$41.9B
$18.8B
Q4 25
$41.9B
$18.5B
Q3 25
$42.0B
$18.0B
Q2 25
$42.5B
$17.5B
Q1 25
$42.0B
$14.0B
Q4 24
$42.6B
$13.3B
Q3 24
$44.2B
$11.9B
Debt / Equity
EMR
EMR
LPLA
LPLA
Q2 26
0.66×
Q1 26
0.66×
Q4 25
0.37×
1.36×
Q3 25
0.44×
1.49×
Q2 25
0.42×
1.41×
Q1 25
0.42×
1.82×
Q4 24
0.32×
1.87×
Q3 24
0.36×
1.60×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EMR
EMR
LPLA
LPLA
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$694.0M
FCF MarginFCF / Revenue
15.2%
Capex IntensityCapex / Revenue
4.0%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$4.6B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EMR
EMR
LPLA
LPLA
Q2 26
Q1 26
Q4 25
$699.0M
$785.0M
Q3 25
$3.1B
$-1.7B
Q2 25
$1.1B
$193.3M
Q1 25
$241.0M
$339.8M
Q4 24
$777.0M
$-178.8M
Q3 24
$3.3B
$209.3M
Free Cash Flow
EMR
EMR
LPLA
LPLA
Q2 26
$694.0M
Q1 26
$602.0M
Q4 25
$602.0M
$613.3M
Q3 25
$2.7B
$-1.9B
Q2 25
$977.0M
$56.3M
Q1 25
$154.0M
$220.3M
Q4 24
$694.0M
$-344.3M
Q3 24
$2.9B
$62.3M
FCF Margin
EMR
EMR
LPLA
LPLA
Q2 26
15.2%
Q1 26
13.9%
Q4 25
13.9%
12.4%
Q3 25
54.9%
-41.1%
Q2 25
21.5%
1.5%
Q1 25
3.5%
6.0%
Q4 24
16.6%
-9.8%
Q3 24
63.1%
2.0%
Capex Intensity
EMR
EMR
LPLA
LPLA
Q2 26
4.0%
Q1 26
2.2%
0.0%
Q4 25
2.2%
3.5%
Q3 25
8.9%
3.1%
Q2 25
2.0%
3.6%
Q1 25
2.0%
3.3%
Q4 24
2.0%
4.7%
Q3 24
9.1%
4.7%
Cash Conversion
EMR
EMR
LPLA
LPLA
Q2 26
Q1 26
Q4 25
1.16×
2.61×
Q3 25
4.86×
Q2 25
1.83×
0.71×
Q1 25
0.50×
1.07×
Q4 24
1.33×
-0.66×
Q3 24
3.35×
0.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EMR
EMR

Segment breakdown not available.

LPLA
LPLA

Advisory$2.6B53%
Sales-based$705.4M14%
Trailing$486.6M10%
Client cash$445.3M9%
Other$394.5M8%
Service and fee$211.0M4%
Transaction$80.5M2%

Related Comparisons